Matt Kaeberlein on which longevity supplements might really work, and which don’t
from In the Know with Amol Sarva Hosted by Amol Sarva
Professor Matt Kaeberlein is an outspoken proponent of rapamycin, and pretty skeptical about virtually all the other interventions people talk most about. Here he lays out a pretty complete and persuasive model for why and how aging happens at all, and why some approaches are most likely to work.
Embed this episode
No transcript yet.
Similar episodes
Frequently asked questions
How long is this episode of In the Know with Amol Sarva?
This episode is 50 minutes long.
When was this In the Know with Amol Sarva episode published?
This episode was published on July 10, 2023.
Can I download this In the Know with Amol Sarva episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.